Which companies overlap with MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA's portfolio?

Top competitors by shared drug class: Galderma R&D.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mip-brasil-ind-stria-e-com-rcio-de-produtos-farmac-uticos-ltda.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ciclopirox 8%	Ciclopirox 8%	marketed	Topical antifungal agent	Fungal cytochrome P450 enzymes and polyvalent cation-dependent metalloenzymes	Dermatology/Infectious Disease

Therapeutic area mix

Dermatology/Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Galderma R&D · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA:

Cite this brief

Drug Landscape (2026). MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mip-brasil-ind-stria-e-com-rcio-de-produtos-farmac-uticos-ltda. Accessed 2026-05-17.